NEW YORK (Reuters Health) – Measurements of intraocular pressure (IOP) may depend on which eye is measured first, according to a new study published in the Archives of…
NEW YORK (Reuters Health) – Treating high-risk retinopathy of prematurity (ROP) early, before threshold severity is reached, preserves peripheral vision with relatively little reduction in visual field extent.…
NEW YORK (Reuters Health) – Results of an early phase trial indicate that wearing an experimental dual-focus soft contact lens can reduce myopia progression in children, according to…
NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they…
NEW YORK (Reuters Health) – A dexamethasone intravitreal implant is more likely to reduce inflammation and improve vision than a sham treatment in patients with noninfectious uveitis, investigators…
NEW YORK (Reuters Health) – Although large pupil size is viewed by some ophthalmologists as a relative contraindication to undergoing LASIK, preoperative pupil size does not affect quality…
NEW YORK (Reuters Health) – Patients with age-related macular degeneration treated with the anti-VEGF monoclonal antibodies bevacizumab and ranibizumab do not have any higher rates of mortality, MI…
NEW YORK (Reuters Health) – Intravitreal injection of clindamycin and dexamethasone to treat active ocular toxoplasmosis appears to be an alternative, and perhaps preferable, to classic treatment with…
NEW YORK (Reuters Health) – Outcomes in patients with coexistent glaucoma and cataracts who undergo simultaneous trabeculectomy and lens extraction are no different whether the two procedures are…
Robert Goldberg, MD, Frank Dabby Professor, Opthalmology Chief, Orbital and Opthalmic Plastic Surgery, UCLA, discusses treatment for Graves Eye Disease, which mainly focuses on medical therapy. IV steroids…